Skip to content

Emergent Biosolutions EBS Business Segments

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Total revenues by Business
Commercial Products$42.9M-5.3%$38.4M-41.0%$74.9M-21.4%$67.5M-43.8%$45.3M-61.8%
MCM Products$101.8M-35.0%$99.2M-15.1%$142.5M-18.2%$58.4M-7.9%$156.6M+0.8%
Segment adjusted gross margin reportable segments: by Business
Commercial Products$16.1M-22.6%$11.8M-63.0%$32.3M-32.8%$31.3M-53.0%$20.8M-68.7%
MCM Products$65.6M-39.1%$53.8M+8.9%$104.6M-17.2%$32.2M-8.3%$107.7M+15.1%
Total depreciation by Business
All other segment$500K-77.3%$800K-68.0%$300K-87.0%$400K-84.6%$2.2M-15.4%
MCM Products$4.6M+9.5%$4.3M0.0%$4.7M0.0%$4.9M-12.5%$4.2M-25.0%
Cost of goods and services sold by Business
Commercial Products$26.8M+9.4%$26.6M-19.9%$42.6M-9.7%$36.2M-32.2%$24.5M-53.0%
MCM Products$36.2M-26.0%$45.4M-32.6%$37.9M-20.9%$26.2M-7.4%$48.9M-20.9%
Total revenues by Product
All other revenue$11.4M-43.8%$11.1M-13.3%$13.7M-43.6%$15M-79.0%$20.3M-23.4%
Commercial Product sales$42.9M-5.3%$38.4M-41.0%$74.9M-21.4%$67.5M-43.8%$45.3M-61.8%
MCM Product sales$101.8M-35.0%$99.2M-15.1%$142.5M-18.2%$58.4M-7.9%$156.6M+0.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Emergent Biosolutions break its business down?
Emergent Biosolutions (EBS) reports total revenues by business across 2 parts — Commercial Products and MCM Products. Each is extracted from the segment footnotes and tracked over time.
Where does Emergent Biosolutions's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Emergent Biosolutions's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.